Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Here you can browse the complete list of publications for PLCO

Publication Year
Title PubMed Authors Journal Year Studies
An early-onset specific polygenic risk score optimizes age-based risk estimate and stratification of prostate cancer: population-based cohort study. 38632662 Cheng Y, Wu L, Xin J, Ben S, Chen S, Li H, Zhao L, Wang M, Cheng G, Du M J Transl Med 2024 PLCO
Circulating microRNAs in association with pancreatic cancer risk within 5 years. 38602070 Wang C, Cai H, Cai Q, Wu J, Stolzenberg-Solomon R, Guo X, Zhu C, Gao YT, Berlin J, Ye F, Zheng W, Setiawan VW, Shu XO Int J Cancer 2024 PLCO
Development and validation of an imageless machine-learning algorithm for the initial screening of prostate cancer. 38571454 Martelin N, De Witt B, Chen B, Eschwège P Prostate 2024 PLCO
Genome-wide association analyses of breast cancer in women of African ancestry identify new susceptibility loci and improve risk prediction. 38741014 Jia G, Ping J, Guo X, Yang Y, Tao R, Li B, Ambs S, Barnard ME, Chen Y, Garcia-Closas M, Gu J, Hu JJ, Huo D, John EM, Li CI, Li JL, Nathanson KL, Nemesure B, Olopade OI, Pal T, Press MF, Sanderson M, Sandler DP, Shu XO, Troester MA, Yao S, Adejumo PO… Nat Genet 2024 PLCO
Effects of joint screening for prostate, lung, colorectal, and ovarian cancer - results from a controlled trial. 38741776 Fan Z, Zhang Y, Yao Q, Liu X, Duan H, Liu Y, Sheng C, Lyu Z, Yang L, Song F, Huang Y, Song F Front Oncol 2024 PLCO
Association between coffee and tea consumption and ovarian cancer incidence: A prospective analysis in the PLCO dataset. 38733325 Huang C, Bu H, Wang Y, Chu R, Zhao W, Liu Y, Wu H, Yao S Int J Cancer 2024 PLCO
Modification Role of Dietary Antioxidants in the Association of High Red Meat Intake and Lung Cancer Risk: Evidence from a Cancer Screening Trial. 39061868 Yang J, Na X, Li Z, Zhao A Antioxidants (Basel) 2024 PLCO
Estimating sojourn time and sensitivity of screening for ovarian cancer using a Bayesian framework. 39038822 Ishizawa S, Niu J, Tammemagi MC, Irajizad E, Shen Y, Lu KH, Meyer LA, Toumazis I J Natl Cancer Inst 2024 PLCO
Adherence to the EAT-Lancet diet reduces the risk of head and neck cancers in 101,755 American adults: a prospective cohort study. 39029269 Ren X, Xiao Y, Xiang L, Peng L, Tang Y, He H, Wang Y, Du Q, Gu H Public Health 2024 PLCO
Absolute risk from double nested case-control designs: cause-specific proportional hazards models with and without augmented estimating equations. 38994640 Lee M, Gail MH Biometrics 2024 PLCO
Prediagnostic whole blood cadmium and molybdenum associated with pancreatic cancer in an American cohort. 38965764 Stolzenberg-Solomon R, Jin D, Huang WY, Brockman J Am J Epidemiol 2024 PLCO
Efficient risk-based collection of biospecimens in cohort studies: Designing a prospective study of diagnostic performance for multicancer detection tests. 38965750 Ramos MLF, Chaturvedi AK, Graubard BI, Katki HA Am J Epidemiol 2024 PLCO
A Linear Relationship between the Number of Cancers among First-Degree Relatives and the Risk of Multiple Primary Cancers. 38867503 He S , Barry KH , Mitchell BD , Chen S , Zhang Y , Beane Freeman LE , Berndt SI Cancer Prev Res (Phila) 2024 PLCO
Risk-stratified screening and colorectal cancer incidence and mortality: A retrospective study from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. 39178994 Zhang Y, Sheng C, Fan Z, Liu Y, Liu X, Duan H, Dai H, Lyu Z, Yang L, Song F, Song F, Huang Y, Chen K Prev Med 2024 PLCO
Potentially functional variants of INPP5D and EXOSC3 in immunity B cell-related genes are associated with non-small cell lung cancer survival. 39176091 Lu G, Liu H, Wang H, Tang X, Luo S, Du M, Christiani DC, Wei Q Front Immunol 2024 PLCO
Preliminary effects of risk-adapted PSA screening for prostate cancer after integrating PRS-specific and age-specific variation. 39149591 Liu X, Duan H, Liu S, Zhang Y, Ji Y, Zhang Y, Feng Z, Li J, Liu Y, Gao Y, Wang X, Zhang Q, Yang L, Dai H, Lyu Z, Song F, Song F, Huang Y Front Genet 2024 PLCO
Potentially functional variants of ERRFI1 in hypoxia-related genes predict survival of non-small cell lung cancer patients. 39096122 Wang H, Liu H, Lu G, Tang X, Luo S, Du M, Christiani DC, Wei Q Cancer Med 2024 PLCO
Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer. 39325441 Kwak S, Wang C, Usyk M, Wu F, Freedman ND, Huang WY, McCullough ML, Um CY, Shrubsole MJ, Cai Q, Li H, Ahn J, Hayes RB JAMA Oncol 2024 PLCO
Potentially functional variants of PARK7 and DDR2 in ferroptosis-related genes predict survival of non-small cell lung cancer patients. 39319523 Wang H, Liu H, Tang X, Lu G, Luo S, Du M, Christiani DC, Wei Q Int J Cancer 2024 PLCO
Associations of minerals intake with colorectal cancer risk in the prostate, lung, colorectal, ovarian cancer screening trial. 39285869 Li S, Ren Q, Song Z, Liu B, Wang D, Shang Y, Wang H Front Nutr 2024 PLCO